FI891870L - 7-deazaguaniner saosom immunomodulatorer. - Google Patents

7-deazaguaniner saosom immunomodulatorer. Download PDF

Info

Publication number
FI891870L
FI891870L FI891870A FI891870A FI891870L FI 891870 L FI891870 L FI 891870L FI 891870 A FI891870 A FI 891870A FI 891870 A FI891870 A FI 891870A FI 891870 L FI891870 L FI 891870L
Authority
FI
Finland
Prior art keywords
immunomodulatorer
deazaguaniner
saosom
saosom immunomodulatorer
deazaguaniner saosom
Prior art date
Application number
FI891870A
Other languages
English (en)
Finnish (fi)
Other versions
FI891870A7 (fi
FI891870A0 (fi
Inventor
Thomas Charles Malone
Jagadish Chandra Sircar
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI891870L publication Critical patent/FI891870L/fi
Publication of FI891870A7 publication Critical patent/FI891870A7/fi
Publication of FI891870A0 publication Critical patent/FI891870A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI891870A 1986-10-24 1987-10-19 7-deazaguaniner saosom immunomodulatorer. FI891870A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92352186A 1986-10-24 1986-10-24
US8623187A 1987-08-20 1987-08-20
PCT/US1987/002727 WO1988003142A2 (fr) 1986-10-24 1987-10-19 7-deazaguanines ayant une activite d'immunomodulateurs

Publications (3)

Publication Number Publication Date
FI891870L true FI891870L (fi) 1989-04-19
FI891870A7 FI891870A7 (fi) 1989-04-19
FI891870A0 FI891870A0 (fi) 1989-04-19

Family

ID=26774505

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891870A FI891870A0 (fi) 1986-10-24 1987-10-19 7-deazaguaniner saosom immunomodulatorer.

Country Status (9)

Country Link
EP (1) EP0327590A1 (fr)
JP (1) JPH02501306A (fr)
KR (1) KR880701721A (fr)
AU (1) AU614947B2 (fr)
CA (1) CA1294960C (fr)
ES (1) ES2008756A6 (fr)
FI (1) FI891870A0 (fr)
GR (1) GR871606B (fr)
WO (1) WO1988003142A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293727C (fr) * 1986-08-26 1991-12-31 Catherine Rose Kostlan 9-deazaguanines
US4968686A (en) * 1988-04-08 1990-11-06 The Regents Of The University Of Michigan Acyclic pyrrolo [2,3-d]pyrimidine analogs as antiviral agents
USRE36187E (en) * 1988-04-08 1999-04-06 The Regents Of The University Of Michigan Acyclic pyrrolo 2,3-d!pyrimidine analogs as antiviral agents
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
DK0460116T3 (da) * 1989-02-27 1998-03-30 Biocryst Pharm Inc 9-substitueret-8-usubstitueret-9-deazaguaniner
AU654264B2 (en) * 1989-10-31 1994-11-03 Biocryst Pharmaceuticals, Inc. Inhibitors of purine nucleoside phosphorylase
US5726311A (en) * 1989-11-29 1998-03-10 Biocryst Pharmaceuticals, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same
US5248672A (en) * 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
EP0766684A4 (fr) * 1994-06-09 1997-07-16 Smithkline Beecham Corp Antagonistes du recepteur de l'endotheline
GB201417165D0 (en) * 2014-09-29 2014-11-12 Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin Treatments for Autoimmune Disease
GB201417163D0 (en) 2014-09-29 2014-11-12 Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748177A (en) * 1984-03-26 1988-05-31 Warner-Lambert Company Guanine derivatives
FR2574407B1 (fr) * 1984-12-12 1987-06-05 Rhone Poulenc Sante Nouveaux derives de la pyrrolo(2,3-d) pyrimidine, leur preparation et les compositions pharmaceutiques qui les contiennent
CA1293727C (fr) * 1986-08-26 1991-12-31 Catherine Rose Kostlan 9-deazaguanines
DE3739366A1 (de) * 1987-04-10 1988-10-27 Boehringer Mannheim Gmbh Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel

Also Published As

Publication number Publication date
FI891870A7 (fi) 1989-04-19
KR880701721A (ko) 1988-11-04
AU8328187A (en) 1988-05-25
AU614947B2 (en) 1991-09-19
EP0327590A1 (fr) 1989-08-16
CA1294960C (fr) 1992-01-28
WO1988003142A2 (fr) 1988-05-25
JPH02501306A (ja) 1990-05-10
GR871606B (en) 1988-02-23
ES2008756A6 (es) 1989-08-01
FI891870A0 (fi) 1989-04-19
WO1988003142A3 (fr) 1988-05-19

Similar Documents

Publication Publication Date Title
DE3767169D1 (de) Sportschuh.
ATE70057T1 (de) Antitumormittel.
ATE57924T1 (de) 3-aryloxy-3-substituierte-propanamine.
FI871178L (fi) Stroemkoppling foer ytmontering.
DE3764043D1 (de) Alkylendiamine.
FI874810A7 (fi) Foerfarande foer vaermestabilisering.
NO166616C (no) Forloesningsbord.
ATE63533T1 (de) Xylolisomerisierung.
FI872819A0 (fi) Vibratorplatta.
FI873155L (fi) Elektrostatiskt sprayfoerfarande.
FI872480L (fi) Seriemagasin foer hagelpatroner.
FI873755A0 (fi) Tvaoskiktssystem.
FI873899A7 (fi) Placeringsanordning foer databehandlingsapparater.
FI874493A0 (fi) Ljusstraolningsanordning foer medicinskt bruk.
FI883713A0 (fi) Enslagstryckluftsverktyg.
FI875473A0 (fi) Foertjockade gjutningskompositioner.
FI882144A7 (fi) Braensleinsprutningsanordning foer dieselmotorer.
FI891870A0 (fi) 7-deazaguaniner saosom immunomodulatorer.
FI874325L (fi) Regleringsanordning och -foerfarande foer vaetsketryck.
FI872605L (fi) Laepplaekemedelsapplikator.
DE3763648D1 (de) Rollski.
FI890701A0 (fi) Byggsystem.
DE3669032D1 (de) Okulopressionsgeraet.
FI875124A0 (fi) Snabbt faestbart knapparrangemang.
FI874537A0 (fi) Daeckslitbanekomposition.

Legal Events

Date Code Title Description
FD Application lapsed
BB Publication of examined application
CD Patent refused following opposition
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY